Bahrain vs East Asia & Pacific (IDA & IBRD countries): Immunization, Hib3
Immunization, Hib3 over time
- Bahrain
- East Asia & Pacific (IDA & IBRD countries)
How they compare
Bahrain currently reports 96.0% against 40.1% in East Asia & Pacific (IDA & IBRD countries), a difference of 55.9%.
That makes Bahrain's figure about 2.4 times East Asia & Pacific (IDA & IBRD countries)'s.
Across all 27 years both countries report, Bahrain has been ahead every year.
Bahrain ranks 46th and East Asia & Pacific (IDA & IBRD countries) ranks 43rd of 191 countries.
Bahrain has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Bahrain | East Asia & Pacific (IDA & IBRD countries) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 67.5% | 0.1% | 67.4% | Bahrain |
| 2000s | 97.6% | 1.2% | 96.4% | Bahrain |
| 2010s | 98.7% | 23.0% | 75.7% | Bahrain |
| 2020s | 97.6% | 36.7% | 60.9% | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Bahrain or East Asia & Pacific (IDA & IBRD countries)?
- Bahrain, at 96.0% against 40.1% in East Asia & Pacific (IDA & IBRD countries) as of 2024.
- What is the difference in immunization, hib3 between Bahrain and East Asia & Pacific (IDA & IBRD countries)?
- 55.9%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and East Asia & Pacific (IDA & IBRD countries)?
- 27 years are reported by both, from 1998 to 2024.
- How do Bahrain and East Asia & Pacific (IDA & IBRD countries) rank globally for immunization, hib3?
- Bahrain ranks 46th and East Asia & Pacific (IDA & IBRD countries) ranks 43rd of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.